Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Colorcon
Healthtrust
Baxter
Mallinckrodt
Dow
QuintilesIMS
Boehringer Ingelheim
US Department of Justice

Generated: February 21, 2019

DrugPatentWatch Database Preview

Litigation for EPCLUSA

« Back to Dashboard

US Court Litigation for EPCLUSA

Patent Trial and Appeal Board Cases for EPCLUSA

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
7,964,580 Initiative for Medicines, Access & Knowledge (I-MAK), Inc. ➤ Sign Up 2017-10-25 2017-10-25 SOFIA et al Inter partes review ➤ Sign Up 2018-05-04 ➤ Sign Up
7,964,580 Initiative for Medicines, Access & Knowledge (I-MAK), Inc. ➤ Sign Up 2017-10-25 2017-10-25 SOFIA et al Inter partes review ➤ Sign Up 2018-05-04 ➤ Sign Up
8,334,270 Initiative for Medicines, Access & Knowledge (I-MAK), Inc. ➤ Sign Up 2017-10-26 2017-11-27 Sofia et al Inter partes review ➤ Sign Up 2018-05-21 ➤ Sign Up
8,334,270 Initiative for Medicines, Access & Knowledge (I-MAK), Inc. ➤ Sign Up 2017-10-26 2017-11-27 Sofia et al Inter partes review ➤ Sign Up 2018-05-21 ➤ Sign Up
8,633,309 Initiative for Medicines, Access & Knowledge (I-MAK), Inc. ➤ Sign Up 2017-10-30 2017-10-30 Ross et al Inter partes review ➤ Sign Up 2018-05-24 ➤ Sign Up
8,735,372 Initiative for Medicines, Access & Knowledge (I-MAK), Inc. ➤ Sign Up 2017-11-09 2017-11-09 Du et al Inter partes review ➤ Sign Up 2018-06-13 ➤ Sign Up
8,889,159 Initiative for Medicines, Access & Knowledge (I-MAK), Inc. ➤ Sign Up 2017-12-26 2017-12-26 Cleary et al Inter partes review ➤ Sign Up 2018-07-19 ➤ Sign Up
Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Colorcon
Express Scripts
Deloitte
AstraZeneca
Merck
Accenture
Johnson and Johnson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.